APP下载

富马酸依美斯汀缓释胶囊联合胶原贴敷料治疗面部糖皮质激素依赖性皮炎的效果

2023-08-15盛宏潘龙

医学美学美容 2023年13期

盛宏 潘龙

【摘 要】目的 探究富馬酸依美斯汀缓释胶囊联合胶原贴敷料治疗面部糖皮质激素依赖性皮炎的效果。方法 选取2020年3月-2021年12月泰州市疾病预防控制中心收治的120例面部糖皮质激素依赖性皮炎患者作为研究对象,随机分为参照组和研究组,各60例。参照组予以富马酸依美斯汀缓释胶囊治疗,研究组在参照组基础上加入胶原贴敷料治疗,比较两组症状积分、面部皮肤功能、炎性指标以及不良反应发生率。结果 两组治疗后皮肤疼痛、皮肤瘙痒以及皮肤灼热评分均低于治疗前,且研究组低于参照组(P<0.05);两组治疗后面部表皮油脂高于治疗前,且研究组高于参照组(P<0.05);两组治疗后经皮水分丢失量、皮肤红斑量低于治疗前,且研究组低于参照组(P<0.05);两组治疗后IL-2低于治疗前,且研究组低于参照组,两组IFN-γ高于治疗前,且参照组低于研究组(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05)。结论 面部糖皮质激素依赖性皮炎在治疗的过程中给予富马酸依美斯汀缓释胶囊联合胶原贴敷料治疗可更好的缓解面部症状,改善面部皮肤功能,控制炎症反应,药物联合使用未增加不良反应发生率,值得临床应用。

【关键词】富马酸依美斯汀缓释胶囊;胶原贴敷料;面部糖皮质激素依赖性皮炎

中图分类号:R751 文献标识码:A 文章编号:1004-4949(2023)13-0064-04

Effect of Emedastine Difumarate Sustained-release Capsules Combined with Collagen Dressing in the Treatment of Facial Glucocorticoid-dependent Dermatitis

SHENG Hong, PAN Long

(Taizhou Center for Disease Control and Prevention, Taizhou 225300, Jiangsu, China)

【Abstract】Objective To analyze the effect of emedastine difumarate sustained-release capsules combined with collagen dressing in the treatment of facial glucocorticoid-dependent dermatitis. Methods A total of 120 patients with facial glucocorticoid-dependent dermatitis admitted to Taizhou Center for Disease Control and Prevention from March 2020 to December 2021 were randomly divided into reference group and study group, with 60 patients in each group. The reference group was treated with emedastine difumarate sustained-release capsules. The study group was treated with collagen dressing on the basis of the reference group. The symptom scores, facial skin function, inflammatory indexes and incidence of adverse reactions were compared between the two groups. Results After treatment, the scores of skin pain, skin itching and skin burning in the two groups were lower than those before treatment, and those in the study group were lower than those in the reference group (P<0.05). After treatment, the facial epidermal grease of the two groups was higher than that before treatment, and that of the study group was higher than that of the reference group (P<0.05). After treatment, the amount of transcutaneous water loss and skin erythema in the two groups were lower than those before treatment, and those in the study group were lower than those in the reference group (P<0.05). After treatment, IL-2 in the two groups was lower than that before treatment, and that in the study group was lower than that in the reference group, while IFN-γ in the two groups was higher than that before treatment, and that in the reference group was lower than that in the study group(P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05). Conclusion In the treatment of facial glucocorticoid-dependent dermatitis, the treatment of emedastine difumarate sustained-release capsules combined with collagen dressing can better alleviate facial symptoms, improve facial skin function, and control inflammatory response. Meanwhile, the combined use of drugs does not increase the incidence of adverse reactions, which is worthy of clinical application.

【Key words】Emedastine difumarate sustained-release capsules; Collagen dressing; Facial glucocorticoid-dependent dermatitis

面部糖皮质激素依赖性皮炎(facial glucocorticoid-dependent dermatitis)因外用皮质类固醇激素引发,导致依赖并且具有特定临床表现,又被称为面部激素依赖性皮炎,属于临床常见、多发的皮肤疾病之一。该病可在任何年龄段发病,以中青年女性居多,一般在停用激素后数天发病,用药局部出现红斑、炎性水肿,并伴随着不同程度的表皮萎缩、色素沉淀和血管扩张。并且受累部位自觉灼热、灼痛和紧绷感,在皮损消退后局部干燥、瘙痒,洗脸后存在肿胀感。……

登录APP查看全文